Westbourne Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$804K Buy
6,254
+101
+2% +$11.8K 0.33% 73
2026
Q1
$740K Buy
6,153
+510
+9% +$58.9K 0.35% 69
2025
Q4
$594K Buy
5,643
+1,900
+51% +$178K 0.28% 76
2025
Q3
$322K Buy
+3,743
New +$308K 0.15% 97
2025
Q2
Sell
-2,738
Closed -$246K 157
2025
Q1
$246K Buy
+2,738
New +$256K 0.15% 117

Other funds holding MRK

Westbourne Investments's MRK Position: Q2 2026 in Review

Westbourne Investments increased its Merck (MRK) stake by 1.6% in Q2 2026, buying an estimated $11.8K and bringing the position to 6,254 shares worth $804K. The position accounts for 0.33% of the portfolio, ranked #73.

Westbourne Investments first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Westbourne Investments held 6,254 shares of Merck worth $804K as of Q2 2026.
  • Westbourne Investments bought 101 Merck shares in Q2 2026, an estimated $11.8K.
  • Merck made up 0.33% of Westbourne Investments's portfolio in Q2 2026, its #73 holding.
  • Westbourne Investments first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.